Results

Total Results: 1,084 records

Showing results for "phase".

1041. Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
      January 01, 2013 - Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests ! ! Methods Research Report Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Met…

1042. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
      February 01, 2012 - Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=971 Published Online: February 2012 Comparative Effectiveness Re…

1043. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
      August 23, 2012 - rate in the group that used N2O (11.6% vs 19.3% Cesarean rates, P < 0.05and 153 min vs 187 min active phase

1044. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
      November 01, 2013 - these choices considering the input of key informants, including patients, during the topic refinement phase

1045. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
      April 01, 2011 - Takeda has completed a phase 1, randomized, open-label, 2 period, crossover study to evaluate the effect … release (MR) - The objective of the study was to assess the safety of dexlansoprazole MR from the phase … Pediatric patients - Dexlansoprazole is not FDA approved for use in patients less than 18 years of age.1A phase … dexlansoprazole in adolescents 12-17 years of age with symptomatic GERD has been completed.8 A second phase

1046. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections

1047. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections

1048. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
      March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion

1049. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
      March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion

1050. Disposition of Comments for Evidence Report 220 Health Information Exchange (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
      December 15, 2015 - page 9, line 34, these terms are used to describe the form of the HIE, and are accompanied by the phase

1051. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
      December 06, 2016 - We are currently in the validating and testing phase for our performance measures.

1052. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2025 Update of the Evidence Base for the PTSD Trials Standardized Data Repository (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-6-draft-report-update-2025.pdf
      January 01, 2025 - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2025 Update of the Evidence Base for the PTSD Trials Standardized Data Repository Draft Systematic Review Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2025 Update of the Evidence Base for the …

1053. Schwitzer_ECCS2012 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
      July 23, 2012 - Schwitzer_ECCS2012 Slide 1: Addressing  Tensions  When Popular Media and Evidence-­‐Based Care Collide Gary  Schwitzer Publisher,  HealthNewsReview.org Slide 2: Infoxication We are drowning people who are thirsty for just a sip of balanced infor…

1054. McCormack-notes-151008 copy - Teresa (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/mccormack-presentation.pdf
      November 12, 2015 - McCormack-notes-151008 copy - Teresa My talk today is about engaging patients with  low health  literacy. 1 Health literacy is a key factor in securing access to healthcare services. So in my talk today, I’ll talk a little bit about health literacy and what it is, how we measure health literacy and the sta…

1055. Disposition of Comments Report for Comparative Effectiveness Review No. 137 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
      August 06, 2014 - Behavioral Health and Wellness) General Are there any identifiable changes early in the treatment phase … Health and Wellness) General What is the evidence that effects measured at the end of the treatment phase

1056. #06 Developmental Delays ADHD, and Autism (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
      January 01, 2012 - inclusion are those interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase … III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results The table below lists the six topics for which (1) preliminary phase III data were available … Currently interventions such as this humanoid robotic doll are in an early phase of development and

1057. Menopause-Protocol-130612 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
      June 12, 2013 - In the title/abstract screening phase, all references will undergo dual review by a senior and a junior … will be pooled by using the methods of Curtin et al.,39, 40 or if not possible, using only the first phase … While complete specification of data to be extracted will be developed during the abstraction phase, … Phase III evaluation of fluoxetine for treatment of hot flashes.

1058. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
      December 31, 2013 - inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase

1059. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
      December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists two topics for which (1) preliminary phase III data for drugs or phase … fecal microbiota therapy for ulcerative colitis that are in clinical trials but have not yet reported phase

1060. autism-update-protocol-130920 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
      September 20, 2013 - Question 3 Are there any identifiable changes early in the treatment phase that predict treatment … Question 4 What is the evidence that effects measured at the end of the treatment phase predict long … reference lists of articles that are included after the full-text review phase